340bemployed.org

Your Free Source for 340B News and Commentary

  • Home
  • About Us
  • Employers
  • Job Seekers
  • Advertise
  • 340B Health

Report: Patient Groups Mum on High Drug Costs


 

Print Article

February 23, 2017—Big Pharma pours so much money into patient advocacy groups that the dough renders them mute on the drug price issue, according to a trenchant piece in USAToday.

“The National Patient Advocate Foundation receives 60 percent of its $2 million budget from the pharmaceutical industry, while the Colon Cancer Alliance gets 15 percent of its $1.2 million budget,” says the publication. “Several other groups get up to 20 percent of their revenue from drug companies.”

And surprise, surprise: NPAF and CCA have been harsh critics of the 340B drug discount program.

We’ve highlighted these conflicts of interest before but the alarm can’t be sounded often enough. While there are natural reasons drug companies and disease advocacy groups work closely, the enormous money spent gives the industry a convenient check on organized patient criticism on nearly any issue.

That investment has paid off handsomely in the drug pricing fight now gripping Washington. Currently, insurance companies and health providers are facing off against Big Pharma with hardly a patient in sight. Some patient groups put drug costs far down the list of priorities. “NPAF’s 2015 data on calls from about 14,000 cancer patients shows transportation was the top concern, followed by hospital and doctor co-pays, rent and mortgages and then prescription co-pays,” says the USAToday story.

Such is the power of the drug industry, even as it stumbles consistently in its effort to counter public ire over astronomical prices.

For a more realistic view of the situation, a new report in the Journal Cancer indicates some patients are cutting corners on their own treatment to avoid high drug bills.

340B helps needy patients avoid these impossible situations. Each day, thousands of Americans receive free or discounted medications and clinical services thanks to the program.

Follow us on X

340B Health Follow

340B Health is the leading advocate & resource for hospitals that serve their communities by participating in the 340B drug pricing program. #Protect340B

340BHealth
340bhealth 340B Health @340bhealth ·
10 Jul

Our member hospitals helped educate lawmakers about harmful #340B provisions as they considered language for the major tax and spending bill.

While those provisions ultimately were not included, we will continue working with our advocacy partners to prevent harmful and…

Reply on Twitter 1943284569454870868 Retweet on Twitter 1943284569454870868 Like on Twitter 1943284569454870868 1 Twitter 1943284569454870868
340bhealth 340B Health @340bhealth ·
9 Jul

#340B hospitals are subject to strict oversight and auditing, and according to a recent @ahahospitals analysis, they received findings at far lower rates than drugmakers from 2018 – 2022.
As drugmakers continue pushing 340B rebates, let’s ensure all stakeholders are maintaining…

American Hospital Association @ahahospitals

AHA report: Hospitals are complying with 340B rules, but drug companies are not: https://ow.ly/jmSe50WaplB #AHAToday

Reply on Twitter 1942971508608880840 Retweet on Twitter 1942971508608880840 Like on Twitter 1942971508608880840 Twitter 1942971508608880840
340bhealth 340B Health @340bhealth ·
8 Jul

Tennessee’s law protecting #340B pharmacy partnerships stays in effect, per a federal judge in Nashville.
The judge found our amicus brief persuasive and denied @AbbVie’s request to stop the state from enforcing that law.
Alongside our national and regional hospital and…

Reply on Twitter 1942562310955966957 Retweet on Twitter 1942562310955966957 Like on Twitter 1942562310955966957 1 Twitter 1942562310955966957
Load More

RSS 340B Informed

  • An In-Depth Look at Total 340B Purchases
  • Ideas for 340B Changes Could Lead to Legislation
  • Help From 340B After a Rare Diagnosis and an Unaffordable Bill

Copyright © 2025 · 340B Health